Recent studies suggest that various chemotherapeutic drugs, including 5-Fluorouracil, arsenic trioxide, and paclitaxel, can trigger SG assembly, which may contribute to the development of chemotherapy resistance.50–52 This observation highlights the potential of targeting HNRNPA1 or ZMYND11 to overcome resistance to cancer therapies. This evidence concerns the gene HNRNPA1 and cancer.